Weal and woe of interleukin-18 in the T cell therapy of cancer

Kessel, Christoph and Rossig, Claudia and Abken, Hinrich (2025) Weal and woe of interleukin-18 in the T cell therapy of cancer. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 13 (1): e010545. ISSN 2051-1426

Full text not available from this repository. (Request a copy)

Abstract

Chimeric antigen receptor (CAR) T cell therapy of solid cancer remains below expectations; adding cytokine help through IL-18 has shown remarkable efficacy in first clinical trials. As IL-18 is also a powerful driver of hyperinflammatory conditions, we discuss to what extent unleashing IL-18 is a double-edged sword in CAR T cell therapies.

Item Type: Article
Uncontrolled Keywords: MACROPHAGE ACTIVATION SYNDROME; IFN-GAMMA; DISEASE; IL-18; AUGMENTATION; RUXOLITINIB; EMAPALUMAB; CHILDREN; MODELS
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 11 Nov 2026 06:30
Last Modified: 11 Nov 2026 06:30
URI: https://pred.uni-regensburg.de/id/eprint/66388

Actions (login required)

View Item View Item